Natasha Kekre
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation 30
- Acute Myeloid Leukemia Research 10
- Oncology top 5%
- CAR-T cell therapy research 25
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments 8
- Pharmacology top 5%
- Genetics top 5%
-
- Acute Lymphoblastic Leukemia research 8
-
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 5
-
- Health Systems, Economic Evaluations, Quality of Life 5
- Co-authors
- Joseph H. AntinSiyaram PandeyJames McNultyAndrew J. McLachlanJean M. ConnorsDavid AllanHarold AtkinsCarly Griffin
- Cited by
- HematologyOncologyTransplantation
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Natasha Kekre
78 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Hematology 513
- Oncology 649
- Transplantation 59
- Pharmacology 160
- Genetics 195
Countries citing papers authored by Natasha Kekre
This map shows the geographic impact of Natasha Kekre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natasha Kekre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natasha Kekre more than expected).
Fields of papers citing papers by Natasha Kekre
This network shows the impact of papers produced by Natasha Kekre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natasha Kekre. The network helps show where Natasha Kekre may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Natasha Kekre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 2 | |
| 5 | Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trialbreakdown → | 2022 | 186 |
| 6 | 2021 | 5 | |
| 7 | 2021 | 8 | |
| 8 | 2021 | 11 | |
| 9 | 2020 | 13 | |
| 10 | 2020 | 12 | |
| 11 | 2020 | 17 | |
| 12 | 2019 | 132 | |
| 13 | 2019 | 1 | |
| 14 | 2017 | 20 | |
| 15 | 2017 | 1 | |
| 16 | 2017 | 35 | |
| 17 | 2016 | 66 | |
| 18 | 2016 | 6 | |
| 19 | 2014 | 108 | |
| 20 | 2012 | 8 |
About Natasha Kekre
Natasha Kekre is a scholar working on Hematology, Transplantation and Oncology, having authored 82 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (30 papers), CAR-T cell therapy research (25 papers), Acute Myeloid Leukemia Research (10 papers), Renal Transplantation Outcomes and Treatments (8 papers), Acute Lymphoblastic Leukemia research (8 papers), Immune Cell Function and Interaction (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Hematology (513 citations), Oncology (649 citations) and Transplantation (59 citations). Natasha Kekre has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Joseph H. Antin, Siyaram Pandey, James McNulty, Andrew J. McLachlan, Jean M. Connors, David Allan, Harold Atkins, Carly Griffin, Christopher Bredeson and Kednapa Thavorn. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.